Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Sarana Menara Nusantara Tbk. (TOWR) Price & Performance

UBC Medical Indonesia Tbk.Trade
Sarana Menara Nusantara Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Sarana Menara Nusantara Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume), while Sarana Menara Nusantara Tbk. trades at Rp390 (market cap 22.93T, 26.05M 24h volume). The key difference: Sarana Menara Nusantara Tbk. is far larger — about 35.2× UBC Medical Indonesia Tbk.'s market cap, and Sarana Menara Nusantara Tbk. is more actively traded (26.05M versus 848.2K). Which is the better fit depends on your goals.

LABSTOWR
Market Cap
651.75B22.93T
Volume
848.2K26.05M
Lot
8.48K260.47K
Turnover
140.51M10.14B
Average Price
165.66389.48
Value
140.51M10.14B
Indicative Equilibrium Price
168390
Indicative Equilibrium Volume
507.71K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
TOWR
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Sarana Menara Nusantara Tbk.

PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering

Read more on TOWR